| (Values in U.S. Thousands) | Oct, 2017 | Oct, 2016 | Oct, 2015 | Oct, 2014 | Oct, 2013 |
| Sales | 360 | 300 | 9,260 | 3,670 | 390 |
| Sales Growth | +20.00% | -96.76% | +152.32% | +841.03% | -58.95% |
| Net Income | -5,010 | -5,020 | -1,380 | -9,610 | -10,080 |
| Net Income Growth | +0.20% | -263.77% | +85.64% | +4.66% | -137.18% |
Itus Corp (ITUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
ITUS Corporation is developing a platform called Cchek, a series of non-invasive blood tests for the early detection of tumor based cancers.